| Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) R Henriksson, J Capala, A Michanek, SÅ Lindahl, LG Salford, L Franzén, ... Radiotherapy and Oncology 88 (2), 183-191, 2008 | 156 | 2008 |
| Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory M Chadha, J Capala, JA Coderre, EH Elowitz, J Iwai, DD Joel, HB Liu, ... International Journal of Radiation Oncology* Biology* Physics 40 (4), 829-834, 1998 | 150 | 1998 |
| HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents A Puri, G Kramer-Marek, R Campbell-Massa, A Yavlovich, SC Tele, ... Journal of liposome research 18 (4), 293-307, 2008 | 133 | 2008 |
| Molecular imaging of HER2-positive breast cancer: a step toward an individualized ‘image and treat’strategy J Capala, K Bouchelouche Current opinion in oncology 22 (6), 559-566, 2010 | 126 | 2010 |
| Fluorescence lifetime imaging system for in vivo studies M Hassan, J Riley, V Chernomordik, P Smith, R Pursley, SB Lee, ... Molecular imaging 6 (4), 7290.2007. 00019, 2007 | 113 | 2007 |
| Hyperthermia-triggered intracellular delivery of anticancer agent to HER2+ cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2+ affisomes) B Smith, I Lyakhov, K Loomis, D Needle, U Baxa, A Yavlovich, J Capala, ... Journal of controlled release 153 (2), 187-194, 2011 | 112 | 2011 |
| Changes in HER2 expression in breast cancer xenografts after therapy can be quantified using PET and 18F-labeled affibody molecules G Kramer-Marek, DO Kiesewetter, J Capala Journal of Nuclear Medicine 50 (7), 1131-1139, 2009 | 110 | 2009 |
| Design of liposomes containing photopolymerizable phospholipids for triggered release of contents A Yavlovich, A Singh, S Tarasov, J Capala, R Blumenthal, A Puri Journal of thermal analysis and calorimetry 98 (1), 97-104, 2009 | 107 | 2009 |
| Targeted drug delivery and image-guided therapy of heterogeneous ovarian cancer using HER2-targeted theranostic nanoparticles M Satpathy, L Wang, RJ Zielinski, W Qian, YA Wang, AM Mohs, ... Theranostics 9 (3), 778, 2019 | 101 | 2019 |
| The quantitative imaging network: NCI's historical perspective and planned goals LP Clarke, RJ Nordstrom, H Zhang, P Tandon, Y Zhang, G Redmond, ... Translational oncology 7 (1), 1-4, 2014 | 98 | 2014 |
| Nanoscintillator conjugates as photodynamic therapy-based radiosensitizers: calculation of required physical parameters NY Morgan, G Kramer-Marek, PD Smith, K Camphausen, J Capala Radiation research 171 (2), 236-244, 2009 | 98 | 2009 |
| HSP90 inhibitor, DMAG, synergizes with radiation of lung cancer cells by interfering with base excision and ATM-mediated DNA repair TT Koll, SS Feis, MH Wright, MM Teniola, MM Richardson, AI Robles, ... Molecular cancer therapeutics 7 (7), 1985-1992, 2008 | 95 | 2008 |
| Computational dosimetry and treatment planning for boron neutron capture therapy DW Nigg, FJ Wheeler, DE Wessol, J Capala, M Chadha Journal of neuro-oncology 33, 93-103, 1997 | 92 | 1997 |
| ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer K Feldinger, D Generali, G Kramer-Marek, M Gijsen, TB Ng, JH Wong, ... Oncotarget 5 (16), 6633, 2014 | 91 | 2014 |
| Ligand liposomes and boron neutron capture therapy J Carlsson, EB Kullberg, J Capala, S Sjöberg, K Edwards, L Gedda Journal of neuro-oncology 62, 47-59, 2003 | 84 | 2003 |
| Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging K Bouchelouche, B Turkbey, P Choyke, J Capala Current urology reports 11, 180-190, 2010 | 82 | 2010 |
| An improved neutron collimator for brain tumor irradiations in clinical boron neutron capture therapy HB Liu, DD Greenberg, J Capala, FJ Wheeler Medical Physics 23 (12), 2051-2060, 1996 | 81 | 1996 |
| Active targeting using her‐2‐affibody‐conjugated nanoparticles enabled sensitive and specific imaging of orthotopic her‐2 positive ovarian tumors M Satpathy, L Wang, R Zielinski, W Qian, M Lipowska, J Capala, GY Lee, ... Small 10 (3), 544-555, 2014 | 80 | 2014 |
| The crosstalk between EGF, IGF, and Insulin cell signaling pathways-computational and experimental analysis R Zielinski, PF Przytycki, J Zheng, D Zhang, TM Przytycka, J Capala BMC systems biology 3, 1-10, 2009 | 79 | 2009 |
| The role of nuclear medicine in modern therapy of cancer G Kramer-Marek, J Capala Tumor Biology 33, 629-640, 2012 | 78 | 2012 |
